| Literature DB >> 32395049 |
Hiroki Nagasawa1, Kazuhiko Omori1, Ikuto Takeuchi1, Youichi Yanagawa1.
Abstract
CONTEXT: Few reports have investigated the time course of fibrinogen (or fibrin) degradation product (FDP) levels for trauma patients in the subacute phase. AIMS: This study aimed to investigate the time course of the FDP levels among patients with moderate and severe trauma in the subacute phase. SETTINGS ANDEntities:
Keywords: Fibrinogen degradation product; injury severity score; time course
Year: 2020 PMID: 32395049 PMCID: PMC7204962 DOI: 10.4103/JETS.JETS_105_19
Source DB: PubMed Journal: J Emerg Trauma Shock ISSN: 0974-2700
Figure 1Flow diagram of the present study. Among 907 patients treated in our department, 40 cases were enrolled as participants
Background characteristics of participants
| Variables | Results |
|---|---|
| Sex (male/female) | 29/11 |
| Age (years) | 64.1±18.7 |
| Mechanism: Blunt/penetrating | 39/1 |
| Traumatic lesion in total (abbreviated injury scale >2) (%) | |
| Head | 10 (25) |
| Chest | 22 (55) |
| Abdomen | 11 (27.5) |
| Pelvis | 15 (37.5) |
| Spine | 15 (37.5) |
| Extremity | 19 (47.5) |
| Systolic blood pressure (mmHg) | 118.7±30.1 |
| Heart rate (beats/min) | 85.5±19.9 |
| Glasgow coma scale | 14 (14–15) |
| Injury severity score | 15.7±7.1 |
| Complication of infection (%) | 12 (30) |
| Surgical management on the 1st hospital day (%) | 20 (50) |
| Surgical management after the 1st hospital day (%) | 6 (15) |
| Enhanced whole-body computed tomography after hospital day 5 (%) | 17 (42.5) |
| Enhanced computed tomography and/or ultrasound sonography for the screening of deep-venous thrombosis of the lower extremity (%) | 2 (5) |
| Anticoagulation therapy before hospital day 7 (%) | 3 (6) |
| Duration of admission (day) | 27.5±23.1 |
| Survival ratio (%) | 100 |
Time course of fibrinogen degradation product level (μg/ml) among all participants
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | |
|---|---|---|---|---|---|---|---|
| 40 | 40 | 40 | 40 | 40 | 19 | 4 | |
| Mean±SD | 187±224 | 47±62 | 15±14 | 12±9 | 18±11 | 28±20 | 23±19 |
| <0.0001 | <0.001 | <0.05 | <0.0001 | 0.01 | NS |
Each FDP level on a given day is compared with that on the previous day. SD: Standard deviation, FDP: Fibrinogen degradation product, NS: Not significant
Figure 2The time course of the fibrinogen (or fibrin) degradation product level in each participant. The average fibrinogen (or fibrin) degradation product level on the 2nd and 3rd hospital day was significantly lower than on respective previous days
Figure 3The average level of fibrinogen (or fibrin) degradation product was significantly lower on the 4th hospital day compared with the 3rd; however, the average level on the 5th hospital day was significantly higher than on the 4th
Time course of fibrinogen degradation product level (μg/ml) excluding surgical procedures after the 1st hospital day and complications of infection
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | |
|---|---|---|---|---|---|---|---|
| 21 | 21 | 21 | 21 | 21 | 9 | 2 | |
| Mean±SD | 203±234 | 36±31 | 12±10 | 10±5 | 16±10 | 18±5 | 29±31 |
| <0.01 | <0.001 | <0.05 | <0.001 | <0.05 |
Each FDP level on a given day is compared with that on the previous day. SD: Standard deviation, FDP: Fibrinogen degradation product
Comparison of the platelet count, prothrombin time, activated partial thromboplastin time, fibrinogen, and fibrinogen degradation product between the 1st and 5th hospital days
| Day 1 | Day 5 | ||
|---|---|---|---|
| Platelet count (×104/mm3) | 19.3±6.5 | 14.7±7.4 | <0.0001 |
| Prothrombin time (s) | 11.9±1.3 | 12.2±2.9 | NS |
| Activated partial thromboplastin time (s) | 27.7±4.1 | 30.3±11.2 | NS |
| Fibrinogen (mg/dl) | 246.4±92.1 | 491.1±150.7 | <0.0001 |
| FDP level (µg/ml) | 187.3±224.0 | 18.9±11.8 | <0.0001 |
NS: Not significant, FDP: Fibrinogen degradation product